Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided Procedures

NCT05121233 — Phase 4, Unknown, 100 participants, Assiut University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT05121233
StatusUnknown
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: quadruple, supportive care
Enrollment100 (Estimated)
SponsorAssiut University (Other)
ConditionsPleural Neoplasms, Aspiration, Respiratory, Pleural Effusion, Lung Neoplasms, Pneumothorax, Pyothorax
InterventionsDiclofenac, Placebo (Drug)
Datesstart 2021-11-01 (estimated), primary completion 2022-10-01 (estimated), completion 2022-10-01 (estimated), first posted 2021-11-16, last updated 2021-11-16

Related Papers Related Patents Related Grants Related Experts
All trials for Pleural Neoplasms All trials for Aspiration, Respiratory All trials of Diclofenac All trials of Placebo

-Summary

This study aims to evaluate the efficacy of single dose analgesia in combination with local anesthesia to control pain during Trans Ultrasound guided procedures. It also aims to assess the effect of its use on procedure performance time and rate of complications occurrence compared to local anesthesia alone.

Expand all sections  ·  Collapse all

+Detailed description

Interventional thoracic ultrasonography (TUS) includes both diagnostic and therapeutic procedures. Fine-needle aspiration biopsy , Tru-cut Pleural or lung parenchymal biopsy and Cope or Abrams needles pleural biopsies are examples of diagnostic procedures while ultrasound guided thoracentesis, pleural aspiration for pneumothorax, placement of chest tubes, and indwelling catheter insertion, or pleurodesis are common therapeutic procedures.

Thoracic ultrasound guided procedures are safe and tolerable. Pain, pneumothorax, bleeding, infection, and procedure failure are the possible complications of TUS guided procedures. Lidocaine 1% should be infiltrated prior to the procedure, paying particular attention to the skin, periosteum and the pleura as a local anesthesia.

To reduce pain, analgesia should be considered as premedication. Despite the apparent common sense of this approach, there is little established evidence of the effect from these medications.

+Arms and interventions

ArmTypeInterventionsDescription
DiclofenacActive comparatorDrug: DiclofenacGroup A will receive a single dose 75 mg IV diclofenac by infusion prior to the procedure
PlaceboPlacebo comparatorDrug: PlaceboGroup B who will receive placebo
  • Diclofenac (Drug): a single dose 75 mg IV diclofenac by infusion prior to the procedure
  • Placebo (Drug): single dose iv placebo (saline ) by infusion prior to the procedure

+Outcome measures

Primary outcomes

  • Pain intensity assessed by Numerical Rating Scale (NRS) [30 minutes]: evaluate the efficacy of single dose analgesia in combination with local anaesthesia to control pain during TUS guided procedures by Numerical Rating Scale , patient is asked to indicate his/her perceived pain intensity , the patient grades their own pain on a scale between 1 to 10
  • Satisfaction assessed by the Visual Analogue Scale (VAS) [30 minutes]: satisfaction assessment by Visual Analogue Scale , series of faces ranging from a happy face at 0, or "no hurt", to a crying face at 10, which represents "hurts like the worst pain imaginable"
  • performance time of transthoracic ultrasound guided procedures [up to 20 minutes]: assess the effect of its use with local anaesthesia on procedure performance compared to local anaesthesia alone

+Eligibility

Sex: All, ages: 18 Years to 75 Years

Inclusion Criteria:

* Adult patients of both genders.
* Patients with pleural effusion, pneumothorax, lung mass or chest wall mass accessible for thoracic ultrasound guided intervention

Exclusion Criteria:

* Children and patients less than 18 years old.
* Pregnant and lactating ladies.
* Patients with disturbed level of consciousness.
* Patients with known bleeding disorders.
* Patients with advanced liver and kidney disorders.
* Patients with known hypersensitivity to NSAIDS.
* Patients with chronic chest diseases.
* Patients who refuse to participate in the trial

+Publications

  • Almolla J, Balconi G. Interventional ultrasonography of the chest: Techniques and indications. J Ultrasound. 2011 Mar;14(1):28-36. doi: 10.1016/j.jus.2011.01.005. Epub 2011 Feb 12. PMID 23396954
  • Havelock T, Teoh R, Laws D, Gleeson F; BTS Pleural Disease Guideline Group. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010 Aug;65 Suppl 2:ii61-76. doi: 10.1136/thx.2010.137026. No abstract available. PMID 20696688
  • Rahman NM, Pepperell J, Rehal S, Saba T, Tang A, Ali N, West A, Hettiarachchi G, Mukherjee D, Samuel J, Bentley A, Dowson L, Miles J, Ryan CF, Yoneda KY, Chauhan A, Corcoran JP, Psallidas I, Wrightson JM, Hallifax R, Davies HE, Lee YC, Dobson M, Hedley EL, Seaton D, Russell N, Chapman M, McFadyen BM, Shaw RA, Davies RJ, Maskell NA, Nunn AJ, Miller RF. Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial. JAMA. 2015 Dec 22-29;314(24):2641-53. doi: 10.1001/jama.2015.16840. PMID 26720026
  • Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969 Oct;62(10):989-93. doi: 10.1177/003591576906201005. No abstract available. PMID 4899510